A clinic dedicated exclusively to intravenous (IV) ibogaine therapy.
Physician-supervised IV ibogaine infusion — screening first, continuous cardiac monitoring, structured integration afterward.
Join the waitlist · Early access
Now accepting waitlist intakes for two locations: Mexico and Gabon.
Ready for more? Full application · Free confidential call
Ibogaine Infusion is a clinic dedicated exclusively to physician-supervised IV ibogaine therapy, with waitlist intakes at two locations: Mexico and Gabon (not an approved U.S. clinic treatment). Ibogaine remains Schedule I in the United States and is not approved for any indication. Availability abroad is not a guarantee of suitability, legality for any individual, or clinical outcome. Cardiac screening and continuous monitoring remain essential. This is educational information, not legal or medical advice.
Apply →Route matters
Why we work exclusively with intravenous ibogaine and what the evidence does and doesn’t show.
The route we offer
Most studied
Not offered
IV ibogaine is still being researched, and every route carries serious cardiac risk, so screening is essential. Nothing here is a promise of cure or benefit.
Request early access
Now accepting waitlist intakes for two locations: Mexico and Gabon.
Small cohorts
Every infusion runs with one-to-one continuous cardiac monitoring, so places in each cohort are limited.
Screening first
A physician reviews your history and ECG before any place is offered. Joining is not admission.
First access
Waitlist members are contacted first for screening and the intake date, on WhatsApp.
Join the waitlist
The ecosystem
Four disciplines held together: medical screening, route honesty, monitored infusion, and integration. Curiosity is welcome; cure claims are not.
01
Cardiac history, ECG, medications, and a clear go/no-go before any infusion conversation begins.
02
Ibogaine itself by intravenous infusion — not oral dosing labeled as an “infusion.”
03
Physician oversight, continuous telemetry, and a medical setting designed for dignity.
04
Structured psychosocial planning after the acute window — deliberate, not ornamental.
Clarity
Most published literature describes oral ibogaine — often with IV magnesium support. Controlled evidence for psychoactive IV ibogaine remains sparse. We say so plainly. Read the definition.
Non-negotiable
The setting
White-coat medical care — not hospitality theater. A monitored medical infusion setting where continuous telemetry is non-negotiable. Intakes in Mexico and Gabon.
How the journey worksDiligence
Screening decides whether an infusion conversation begins — not a sales call. Journey shape may resemble infusion-clinic care; that is not legal, evidence, or risk equivalence with ketamine.
Visit FAQTrue transformation starts with refusal of shortcuts.
No invented outcomes for addiction, depression, or PTSD. No marketing “infusion” for oral flood dosing. Support IV ≠ psychoactive IV.
Educational only · Not medical advice
Questions
Straight answers on route, screening, and evidence — without marketing fog.
Visit full FAQIV lets clinicians titrate the dose in small increments and slow or stop the infusion, under continuous ECG/QTc monitoring. Oral is the most studied route but cannot be reversed once swallowed. Intranasal has very little clinical data. IV ibogaine is still being researched and every route carries serious cardiac risk. See /iv-vs-oral.
Intravenous delivery of ibogaine as the psychoactive treatment under physician supervision in a medical infusion setting, with cardiac screening, continuous monitoring, and integration afterward.
Ibogaine Infusion is a clinic dedicated exclusively to physician-supervised IV ibogaine therapy, with waitlist intakes at two locations: Mexico and Gabon. That is not the same as approved care in the United States. Ibogaine remains Schedule I federally and is not approved for any indication. Foreign availability is not legal advice, not a guarantee you will qualify, and not a prediction of benefit or safety. See /safety-and-screening and /blog/is-ibogaine-legal-us (educational only).
Yes. Landmark examples include Knuijver et al. (Addiction, 2021; oral HCl, QTc) and Cherian et al. (Nature Medicine, 2024; oral ibogaine + IV magnesium). Controlled IV-psychoactive evidence is sparse.
No. It is not approved for any indication and is Schedule I in the United States.
Yes. Ibogaine can prolong QTc. Screening and continuous monitoring are ethical and clinical non-negotiables for any medical program.
Read safety and how-it-works education, then submit a confidential application at /apply.
Journal
2026-09-06 · 10 min
Schenberg et al. Brazil series: ibogaine plus psychotherapy and abstinence in mostly cocaine/crack users—oral≠IV; no cures; QTc; Schedule I.
Read →2026-09-06 · 10 min
Animal study: Marton et al. 2019 Frontiers—ibogaine alters GDNF/BDNF expression in rats; not human IV evidence; no cures; QTc still relevant clinically.
Read →2026-09-06 · 10 min
Human ibogaine pharmacokinetics: Glue 2015 CYP2D6 20 mg volunteer study, with Knuijver 2024 context; oral≠IV; QTc.
Read →The path
Each step is curated for safety and clarity — not urgency.
01
Read the definition of true IV infusion, the evidence gap, and what cardiac diligence requires — before any application.
02
Submit a confidential multi-step application. We review readiness signals and schedule a discovery conversation.
03
ECG, labs as indicated, medication review, and physician go/no-go. Intakes are in Mexico and Gabon.
04
Psychoactive intravenous ibogaine under continuous telemetry and physician supervision in a medical setting.
05
Aftercare planning that translates the acute window into grounded next steps — without outcome promises.
